- (1) Harm reduction services provided by an entity funded under ORS 430.389(2) must be low-barrier and must reduce the negative individual and public health outcomes of substance use and substance related harm.
(2) Harm reduction services provided by a funded entity can include but are not limited to:
- (a) Access to naloxone;
- (b) Sterile syringes;
- (c) Safer use and wound care supplies;
- (d) Substance use-related infectious disease screening;
- (e) Sobering support;
- (f) Contingency management;
- (g) Drug checking supplies; and
- (h) Information and education about harm reduction services.
- (i) Referral for Hepatitis, HIV, STI, COVID-19, and Tuberculosis (TB) testing, vaccine, or other healthcare services.
Statutory/Other Authority
ORS 430.389, 430.390 & 430.391
Statutes/Other Implemented
ORS 430.383 & 430.392
History
DTRS 3-2024, adopt filed 10/22/2024, effective 11/01/2024
DTRS 1-2024, temporary adopt filed 05/30/2024, effective 06/01/2024 through 11/27/2024